-
Innovation Ranking
NewInnovation Ranking – ams AG
ams OSRAM AG, formerly, ams AG (ams) is a manufacturer of analog ICs, sensors, and sensing solutions. The company’s product portfolio comprise sensor ICs, interfaces, and technology solutions. It provides 3D sensors, audio systems, and capacitive and CMOS imaging sensors. ams also carries out the development of smart lighting and power management systems and ASIC solutions. The company provides technology solutions such as Micro Lens Array, an ultra-small projector that integrates images into a micro-optic lens; and VCSEL, a digital...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-003 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-003 in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-003 in Metastatic Melanoma Drug Details: AM-003 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-003 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-003 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-003 in Solid Tumor Drug Details: AM-003 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-003 in Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-003 in Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-003 in Thyroid Cancer Drug Details: AM-003 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-1476 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-1476 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-1476 in Idiopathic Pulmonary Fibrosis Drug Details: AM-1476 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-003 in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-003 in Head And Neck Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-003 in Head And Neck Cancer Drug Details: AM-003...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-003 in Nonmelanomatous Skin Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-003 in Nonmelanomatous Skin Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-003 in Nonmelanomatous Skin Cancer Drug Details: AM-003 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-003 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-003 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-003 in Metastatic Colorectal Cancer Drug Details: AM-003 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AM-003 in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AM-003 in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AM-003 in Soft Tissue Sarcoma Drug Details: AM-003 is under...
-
Product Insights
Kraiburg am Inn community Solar PV Project, Germany
Kraiburg am Inn community Solar PV Project is proposed to be built in Bavaria, Germany. The project is at the permitting stage. Empower your strategies with our Kraiburg am Inn community Solar PV Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...